Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.
Tari Eason's contract uncertainty looms over the Houston Rockets' season, while the Astros face challenges and the Thunder and Lakers navigate their own narratives.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, according to a critical report.
Tari Eason's contract uncertainty looms over the Houston Rockets' season, while the Astros face challenges and the Thunder and Lakers navigate their own narratives.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.